Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Darutigenol

Copy Product Info
😃Good
Catalog No. T3817Cas No. 5940-00-1

Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.

Darutigenol

Darutigenol

Copy Product Info
😃Good
Purity: 99.81%
Catalog No. T3817Cas No. 5940-00-1
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$97-In Stock
2 mg$143-In Stock
5 mg$238-In Stock
10 mg$358-In Stock
25 mgPreferential-In Stock
50 mgPreferentialInquiryInquiry
1 mL x 10 mM (in DMSO)$246-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Darutigenol AI Summary
Darutigenol exhibits a range of biological activities, including moderate cytotoxicity against human HeLa cells with an IC50 value greater than 100.0 µg/mL, as determined by the MTT assay after 44 hours. It also demonstrates anti-inflammatory properties by inhibiting LPS-induced nitric oxide production in mouse RAW264.7 cells, with an IC50 greater than 100,000.0 nM after 24 hours. Additionally, Darutigenol shows anti-invasive effects by inhibiting EGF-induced cell invasion in human MDA-MB-231 cells, with IC50 values greater than 10,000.0 nM and 25,000.0 nM reported for different durations of 3.5 hours and 24 hours, respectively. Moreover, it inhibits human coagulation factor 10a with an IC50 of 11,418.0 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
Chemical Properties
Molecular Weight322.48
FormulaC20H34O3
Cas No.5940-00-1
SmilesC[C@]12[C@]3(C(=C[C@]([C@H](CO)O)(C)CC3)CC[C@@]1(C(C)(C)[C@H](O)CC2)[H])[H]
Relative Density.1.406 g/cm3
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (186.06 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1010 mL15.5048 mL31.0097 mL155.0484 mL
5 mM0.6202 mL3.1010 mL6.2019 mL31.0097 mL
10 mM0.3101 mL1.5505 mL3.1010 mL15.5048 mL
20 mM0.1550 mL0.7752 mL1.5505 mL7.7524 mL
50 mM0.0620 mL0.3101 mL0.6202 mL3.1010 mL
100 mM0.0310 mL0.1550 mL0.3101 mL1.5505 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Darutigenol | purchase Darutigenol | Darutigenol cost | order Darutigenol | Darutigenol chemical structure | Darutigenol formula | Darutigenol molecular weight